ARCHIVES

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

This article is from The Cancer Letter archive.

Vol. 14 No. 43 | November 4, 1988

Download PDF Visit The Full Archive

Related Articles

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

AACR Receives Record Number of Abstracts

January 27, 1989

Drug Development Committee Demands, Gets Greater Voice In Contract Awards, Review of Unsolicited Proposals, Suggests RFP For New Screening Systems

January 2, 1976

Final Issue of the Year

December 13, 1985

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979